Literature DB >> 8340758

Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.

M López-Cabrera1, A G Santis, E Fernández-Ruiz, R Blacher, F Esch, P Sánchez-Mateos, F Sánchez-Madrid.   

Abstract

The activation of T lymphocytes, both in vivo and in vitro, induces the expression of CD69. This molecule, which appears to be the earliest inducible cell surface glycoprotein acquired during lymphoid activation, is involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets. To determine the structural basis for CD69 function, the cDNA coding for CD69 was isolated by a polymerase chain reaction-based strategy using oligonucleotides deduced from peptide sequences of the purified protein. The isolated cDNA exhibited a single open reading frame of 597 bp coding for CD69, and predicted a 199-amino acid protein of type II membrane topology, with extracellular (COOH-terminal), transmembrane, and intracellular domains. The CD69 clone hybridized to a 1.7-kb mRNA species, which was rapidly induced and degraded after lymphocyte stimulation, consistent with the presence of rapid degradation signals at the 3' untranslated region. Transient expression of the polypeptide encoded by CD69 cDNA in COS-7 cells demonstrated that it presented properties comparable to native CD69 protein. The CD69 gene was regionally mapped to chromosome 12 p13-p12 by both somatic cell hybrid DNA analysis and fluorescence in situ hybridization coupled with GTG banding (G bands by trypsin using Giemsa). Protein sequence homology search revealed that CD69 is a new member of the Ca(2+)-dependent (C-type) lectin superfamily of type II transmembrane receptors, which includes the human NKG2, the rat NKR-P1, and the mouse NKR-P1 families of NK cell-specific genes. CD69 also has a structural homology with other type II lectin cell surface receptors, such as the T cell antigen Ly49, the low avidity immunoglobulin E receptor (CD23), and the hepatic asialoglycoprotein receptors. The CD69 protein also shares functional characteristics with most members of this superfamily, which act as transmembrane signaling receptors in early phases of cellular activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340758      PMCID: PMC2191117          DOI: 10.1084/jem.178.2.537

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  57 in total

1.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.

Authors:  J C Reed; J D Alpers; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Cloning and sequencing of cDNA of Sarcophaga peregrina humoral lectin induced on injury of the body wall.

Authors:  H Takahashi; H Komano; N Kawaguchi; N Kitamura; S Nakanishi; S Natori
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

4.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

5.  Molecular structure of human lymphocyte receptor for immunoglobulin E.

Authors:  H Kikutani; S Inui; R Sato; E L Barsumian; H Owaki; K Yamasaki; T Kaisho; N Uchibayashi; R R Hardy; T Hirano
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

6.  Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.

Authors:  B Seed; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins.

Authors:  K Ikuta; M Takami; C W Kim; T Honjo; T Miyoshi; Y Tagaya; T Kawabe; J Yodoi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor.

Authors:  C Lüdin; H Hofstetter; M Sarfati; C A Levy; U Suter; D Alaimo; E Kilchherr; H Frost; G Delespesse
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

9.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Authors:  W H Chambers; N L Vujanovic; A B DeLeo; M W Olszowy; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

Authors:  T Hara; L K Jung; J M Bjorndahl; S M Fu
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  61 in total

1.  T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.

Authors:  Kohei Hosokawa; Sachiko Kajigaya; Keyvan Keyvanfar; Wangmin Qiao; Yanling Xie; Danielle M Townsley; Xingmin Feng; Neal S Young
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

2.  Markers of nonselective and specific NK cell activation.

Authors:  Leslie A Fogel; Michel M Sun; Theresa L Geurs; Leonidas N Carayannopoulos; Anthony R French
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

3.  Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene.

Authors:  B Plougastel; T Jones; J Trowsdale
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 4.  The molecular basis of natural killer (NK) cell recognition and function.

Authors:  L Moretta; M C Mingari; D Pende; C Bottino; R Biassoni; A Moretta
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

5.  Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients.

Authors:  Douglas R McDonald; Frederick Goldman; Oscar D Gomez-Duarte; Andrew C Issekutz; Dinakantha S Kumararatne; Rainer Doffinger; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2010-08       Impact factor: 10.793

6.  Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.

Authors:  J C Lorentzen; A Glaser; L Jacobsson; J Galli; H Fakhrai-rad; L Klareskog; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells.

Authors:  E L Ho; J W Heusel; M G Brown; K Matsumoto; A A Scalzo; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.

Authors:  David Sancho; Manuel Gómez; Fernando Viedma; Enric Esplugues; Mónica Gordón-Alonso; María Angeles García-López; Hortensia de la Fuente; Carlos Martínez-A; Pilar Lauzurica; Francisco Sánchez-Madrid
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

10.  Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.

Authors:  Whitney E Purtha; Karen A Chachu; Herbert W Virgin; Michael S Diamond
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.